CClinicalTrials.gg
Active, not recruitingNCT05157880Updated Jun 12, 2026

Building Resiliency in Dyads of Patients With an ANI Admitted to the Neuro-ICU and Their Informal Caregivers

An interventional study of Recovering Together and Recovering Together in Acute Neurological Injury and Emotional Distress, sponsored by Massachusetts General Hospital. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-12.

Sponsored by Massachusetts General Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
388
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of the present investigation is to test the efficacy of a brief (6 sessions) dyadic (patient and caregiver together) intervention to prevent chronic emotional distress in at risk dyads admitted to a Neuroscience Intensive Care Unit with an acute brain injury. Through this study, we seek to solve the unmet need of preventing chronic emotional distress in Neuroscience Intensive Care Unit (NICU) dyads through a feasible, acceptable and credible program, and ideally improve the recovery trajectory and dyads' overall quality of life.

Read the detailed description

The goals of this study are to: 1) demonstrate the efficacy of Recovering Together for improving self-reported emotional distress (primary outcome), and post traumatic stress, mindfulness, coping, social support and other relevant outcomes (secondary outcomes); and 2) assess mechanisms (mediators and moderators) of improvement after intervention. We will enroll and randomly assign 194 at risk dyads (97 per study group) to receive either the active intervention or educational control. The trial is single blinded (assessors, patients and staff). The trial will take place at the Massachusetts General Hospital NICU using our established methodology successfully implemented during the R21 pilot study. Study clinicians will deliver 6, 30 minute sessions of active intervention or educational control (2 at bedside and 4 via live video after discharge) to each patient-caregiver dyad. All participants will complete measures at baseline, after completion of program (6 weeks) and 3 months later. They will also complete measures of emotional distress weekly, as well as measures assessing home practice.

02

Conditions studied

  • Acute Neurological Injury
  • Emotional Distress

Browse trials for

Keywords

  • Neurological Injury
  • Emotional Distress
  • Dyadic Intervention
03

In context

Trauma, Nervous System

85 studies on the registry are indexed under Trauma, Nervous System; 26 are open to participants now.

This study's planned enrollment of 388 is above the median of 35 across 58 interventional studies indexed under Trauma, Nervous System.

Browse Trauma, Nervous System studies →

Lead sponsor

Massachusetts General Hospital is the lead sponsor of 2,536 studies on the registry; 446 are open to participants now.

Of its 214 completed or terminated interventional studies of FDA-regulated products, 161 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 18 or older
  • English fluency and literacy
  • Patient with an informal caregiver available and willing to participate
  • Hospitalized with any ANI within 6 weeks (patient) OR informal caregiver of a patient currently admitted with any ANI
  • Patient and/or caregiver exhibit emotional distress on screening (using HADS D and/or HADS A scores > 7)

Exclusion criteria

Exclusion Criteria:

  • Permanent cognitive impairment (including severe hearing impairment) or aphasia that makes participation impossible
  • Short form of Mini-Mental State Exam (SMMSE) score \<4 (If SMMSE \<4, nursing team decides whether or not the patient can meaningfully participate)
  • Glasgow Coma Scale (GCS) score \<10
  • Terminal diagnosis
  • Lack of access to internet and/or a device with a camera
  • Current untreated or unstable severe mental health conditions like bipolar disorder, schizophrenia, or active substance use
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
388 participants (estimated)

Study arms

  • Experimental
    Experimental Patient-Caregiver Dyads

    There will be 6 sessions with 2 general sessions delivered in person at bedside in the NICU (or virtual depending on COVID and discharge status) and 4 tailored specific sessions (chosen from by the dyads from 6 available modules) to be delivered via live video using Zoom. Content will be primarily skills.

    Behavioral: Recovering Together

  • Active comparator
    Control Patient-Caregiver Dyads

    There will be 6 sessions with 2 general sessions delivered in person at bedside in the NICU (or virtual depending on COVID and discharge status) and 4 tailored specific sessions (chosen from by the dyads from 6 available modules) to be delivered via live video using Zoom. Content will be primarily educational.

    Behavioral: Recovering Together

Interventions

  • BehavioralRecovering Together

    In the skills-based intervention group, sessions focus on developing skills to cope and manage ANI related stressors. The intervention will be tailored consistent with AHA recommendations for ANI skills-based interventions and will include 2 general and 4 specific modules. It is anticipated that the intervention will have 6 sessions with 2 general sessions delivered, in person if possible, within the NICU, or through live video using Zoom if patients leave the hospital before sessions occur, and 4 tailored specific sessions (chosen from by the dyads from 6 available modules) to be delivered via live video using Zoom.

    Also known as: Skills-based intervention

  • BehavioralRecovering Together

    Those in the educational program will receive general health information that mimics the skills-based intervention, but without teaching any of the resiliency or interpersonal communication skills that are hypothesized to be responsible for improvement in emotional distress. There will also be 6 sessions, 2 in-person dyadic visits in the NICU and 4 dyadic virtual visits following discharge. The educational program group will not have the opportunity to specify which modules they would like to take; the modules will be predetermined. All participants will receive medical care as determined by their medical team.

    Also known as: Educational program

06

What researchers measure

Primary outcomes

  1. Change in Emotional Distress

    Hospital Depression and Anxiety Scale total score (HADS); 0-21 for each subscale (anxiety and depression), higher scores indicate greater anxiety or depression

    Time frame: 0 weeks, 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks, 3 months

Secondary outcomes

  1. Change in Post-Traumatic Stress

    Post-Traumatic Stress Disorder Checklist - Specific Event (PCL-S); 17-85, higher scores indicate greater post-traumatic stress

    Time frame: 0 weeks, 6 weeks, 3 months

  2. Change in Resiliency Factors (Mindfulness - curiosity and de-centering)

    Toronto Mindfulness Scale-Trait (TMS-Trait); 0-52, higher scores indicate greater perceived mindfulness (specifically curiosity and de-centering)

    Time frame: 0 weeks, 6 weeks, 3 months

  3. Change in Resiliency Factors (Mindfulness)

    Cognitive and Affective Mindfulness Scale (CAMS); 12-48, higher scores indicate greater perceived mindfulness

    Time frame: 0 weeks, 6 weeks, 3 months

  4. Change in Resiliency Factors (Individual Coping)

    Measure of Current Status Part A (MOCS-A); 0-52; higher scores indicate greater perceived ability to cope

    Time frame: 0 weeks, 6 weeks, 3 months

  5. Change in Resiliency Factors (Dyadic Coping)

    Dyadic Coping Inventory (DCI); 35-175; higher scores indicate greater perceived coping in the context of a relationship

    Time frame: 0 weeks, 6 weeks, 3 months

  6. Change in Interpersonal Factors (perceived social support)

    Interpersonal Support Evaluation List-12 (ISEL-12); 0-48, higher scores indicate greater perceived social support

    Time frame: 0 weeks, 6 weeks, 3 months

  7. Change in Interpersonal Factors (avoidant or anxious communication)

    Experiences in Close Relationships Scale short form (ECR-S); 7-42, higher scores indicate greater avoidant or anxious communication

    Time frame: 0 weeks, 6 weeks, 3 months

  8. Change in Interpersonal Factors (dyadic strain and positive interpersonal interactions)

    Dyadic Relationship Scale (DRS); Patient version: 10-40, caregiver version: 11-44, dyadic strain subscale: higher scores indicate greater levels of strain, positive dyadic interaction subscale: higher scores indicate greater levels of positive interaction

    Time frame: 0 weeks, 6 weeks, 3 months

Other outcomes

  1. Demographic Factors (potential moderators)

    Age; biological sex; gender; race/ethnicity; educational level; employment status; occupation; income; marital status; prior ANI status; mental health history; psychotropic medications; medical comorbidities; satisfaction with medical staff (analog scale 0-10)

    Time frame: 0 weeks

  2. Change in Independence in activities of daily living (potential moderator)

    Barthel Score; 0-100, higher scores indicate greater independence

    Time frame: 0 weeks, 6 weeks, 3 months

  3. Change in Degree of disability or dependence (potential moderator)

    Modified Rankin; 0-6, higher scores indicate greater disability

    Time frame: 0 weeks, 6 weeks, 3 months

07

Study locations

1 site
  • Massachusetts General Hospital (MGH)
    Boston, Massachusetts 02114, United States
08

References and documents

Publications

  • Vranceanu AM, Woodworth EC, Kanaya MR, Bannon S, Mace RA, Manglani H, Duarte BA, Rush CL, Choukas NR, Briskin EA, Cohen J, Parker R, Macklin E, Lester E, Traeger L, Rosand J; Neuro-ICU Recovering Together Team; Grunberg VA. The Recovering Together study protocol: A single-blind RCT to prevent chronic emotional distress in patient-cargiver dyads in the Neuro-ICU. Contemp Clin Trials. 2022 Dec;123:106998. doi: 10.1016/j.cct.2022.106998. Epub 2022 Nov 8. PubMed 36368480 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05157880
Lead sponsor
Massachusetts General Hospital
Responsible party
Ana-Maria Vranceanu, PhD (Associate Professor/Director, Massachusetts General Hospital) — Principal investigator
First posted
Dec 15, 2021
Start date
Dec 10, 2021
Primary completion
Oct 1, 2026 (estimated)
Completion
Oct 1, 2026 (estimated)
Last update
Jun 12, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion